FHIR IG analytics83,684 resources
By Version
By Authority
By Realm
Start Prev Rows 43200 - 43400 Next
| Package | Version | Identity | Name/Title | Status | FMM | WG | Date | Realm | Auth | Source(s) |
|---|---|---|---|---|---|---|---|---|---|---|
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1078.894.json | Peripheral edema | active | 2024-04 | us | hl7 | vsac | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1078.895.json | TZD Allergy Intolerance | active | 2025-05 | us | hl7 | vsac | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1078.896.json | PIM_Beta_Blockers | active | 2024-11 | us | hl7 | rx | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1078.897.json | PIM_CCB_DHPs | active | 2024-11 | us | hl7 | rx | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1078.898.json | PIM_Loop_Diuretics | active | 2024-04 | us | hl7 | rx | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1078.899.json | PIM_Inhaled_Corticosteroids_(ICS) | active | 2025-03 | us | hl7 | rx | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1078.9.json | ACE inhibitors | active | 2024-12 | us | hl7 | rx | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1078.90.json | ASCVD I10 | active | 2023-09 | us | hl7 | icd | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1078.900.json | PIM_Leukotrienes | active | 2024-04 | us | hl7 | rx | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1078.901.json | OIA_Asthma_COPD_Meds_Inhalers | active | 2025-04 | us | hl7 | rx | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1078.902.json | OIA_Asthma_COPD_Meds_Nebulizers | active | 2024-04 | us | hl7 | rx | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1078.903.json | OIA_Asthma_COPD_Meds_Oral | active | 2024-04 | us | hl7 | rx | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1078.904.json | OIA_GLP1_Injectables | active | 2024-04 | us | hl7 | rx | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1078.905.json | OIA_Insulin_Injectables | active | 2024-04 | us | hl7 | rx | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1078.906.json | OIA_Oral_Hypoglycemics | active | 2024-12 | us | hl7 | rx | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1078.907.json | OIA_DM1_DM2_Meds | active | 2024-10 | us | hl7 | rx | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1078.908.json | Medium Dose ICS Formoterol | active | 2024-05 | us | hl7 | rx | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1078.909.json | High Dose ICS Formoterol | active | 2024-05 | us | hl7 | rx | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1078.910.json | CKD stage5OrESRD I10 | active | 2024-05 | us | hl7 | icd | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1078.911.json | CKD stage5OrESRD SCT | active | 2024-05 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1078.912.json | CKD stage5OrESRD | active | 2024-05 | us | hl7 | vsac | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1078.914.json | Anxiety_I10 | active | 2024-06 | us | hl7 | icd | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1078.915.json | Anxiety_SCT | active | 2024-06 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1078.916.json | Anxiety | active | 2024-06 | us | hl7 | vsac | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1078.918.json | Stress_SCT | active | 2024-06 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1078.919.json | Stress_I10 | active | 2024-06 | us | hl7 | icd | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1078.920.json | Stress | active | 2024-06 | us | hl7 | vsac | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1078.921.json | PBH_Anxiety_SCT | active | 2024-06 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1078.922.json | PBH_Depression_SCT | active | 2024-06 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1078.923.json | PBH_Stress_SCT | active | 2024-06 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1078.924.json | PBH_Insomnia_SCT | active | 2024-06 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1078.925.json | PIM_CMP_CPTs | active | 2024-06 | us | hl7 | cpt | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1078.926.json | Canagliflozin meds | active | 2024-07 | us | hl7 | rx | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1078.927.json | Empagliflozin meds | active | 2024-07 | us | hl7 | rx | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1078.928.json | Dapagliflozin meds | active | 2024-07 | us | hl7 | rx | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1078.929.json | Ertugliflozin meds | active | 2024-07 | us | hl7 | rx | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1078.930.json | Dulaglutide meds | active | 2024-07 | us | hl7 | rx | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1078.931.json | Liraglutide meds | active | 2024-07 | us | hl7 | rx | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1078.932.json | Semaglutide SC meds | active | 2024-07 | us | hl7 | rx | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1078.933.json | T2DM meds benefitting ASCVD | active | 2024-07 | us | hl7 | vsac | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1078.934.json | T2DM meds benefitting CKD stages 2, 3, and 4 with eGFR >= 20 mL/min | active | 2024-07 | us | hl7 | vsac | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1078.935.json | T2DM meds benefitting CKD stage 5 | active | 2024-07 | us | hl7 | vsac | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1078.936.json | T2DM meds benefitting HF with eGFR >= 20 mL/min | active | 2024-07 | us | hl7 | vsac | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1078.938.json | Crohn disease SCT | active | 2024-10 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1078.939.json | Crohn disease I10 | active | 2024-10 | us | hl7 | icd | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1078.940.json | Crohn disease | active | 2024-10 | us | hl7 | vsac | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1078.941.json | Celiac disease SCT | active | 2024-10 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1078.942.json | Celiac disease I10 | active | 2024-10 | us | hl7 | icd | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1078.943.json | Celiac disease | active | 2024-10 | us | hl7 | vsac | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1078.944.json | OIA_Bisoprolol | active | 2024-10 | us | hl7 | rx | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1078.945.json | OIA_PVD_ICD10 | active | 2024-10 | us | hl7 | icd | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1078.946.json | Vibration Controlled Transient Elastography (VCTE) | active | 2024-12 | us | hl7 | cpt | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1078.947.json | OIA_Antihypertensive_Medications | active | 2024-10 | us | hl7 | rx | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1078.950.json | OIA_CAD_ICD10 | active | 2024-10 | us | hl7 | icd | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1078.951.json | OIA_DM_ICD10 | active | 2024-10 | us | hl7 | icd | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1078.952.json | OIA_Creatinine_Levels_LOINC | active | 2024-10 | us | hl7 | loinc | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1078.953.json | OIA_DM_SNOMEDCT | active | 2024-10 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1078.954.json | OIA_CAD_SNOMEDCT | active | 2024-10 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1078.955.json | OIA_PVD_SNOMEDCT | active | 2024-10 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1078.956.json | OIA_DM_ICD10_SNOMEDCT | active | 2024-10 | us | hl7 | vsac | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1078.957.json | OIA_CAD_ICD10_SNOMEDCT | active | 2024-10 | us | hl7 | vsac | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1078.958.json | OIA_PVD_ICD10_SNOMEDCT | active | 2024-10 | us | hl7 | vsac | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1078.959.json | ACEi for HFrEF | active | 2025-01 | us | hl7 | rx | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1078.960.json | ARB for HFrEF | active | 2024-12 | us | hl7 | rx | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1078.961.json | OIA_AntiHTN_Meds_Inclusion_List | active | 2024-11 | us | hl7 | rx | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1078.962.json | OIA_Thiazide_Diuretics | active | 2024-11 | us | hl7 | rx | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1078.963.json | OIA_RFs_ACS_ICD10 | active | 2024-12 | us | hl7 | icd | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1078.964.json | OIA_RFs_ACS_SNOMED | active | 2024-12 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1078.965.json | OIA_RFs_ACS__ICD10_SNOMED | active | 2024-12 | us | hl7 | vsac | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1078.966.json | OIA_Aortic_Calcifications_ICD10 | active | 2025-01 | us | hl7 | icd | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1078.967.json | OIA_Aortic_Calcifications_SNOMED | active | 2025-01 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1078.968.json | OIA_Aortic_Calcifications_ICD10_SNOMED | active | 2025-01 | us | hl7 | vsac | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1078.969.json | OIA_Microalbumin | active | 2025-01 | us | hl7 | loinc | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1078.97.json | Sulfonylurea AllergyIntolerance SCT | active | 2023-09 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1078.970.json | OIA_LDL_Cholesterol | active | 2025-01 | us | hl7 | loinc | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1078.971.json | Pioglitazone | active | 2025-01 | us | hl7 | rx | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1078.972.json | MASLD I10 | active | 2025-02 | us | hl7 | icd | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1078.973.json | MASLD SCT | active | 2025-02 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1078.975.json | OIA_Sulfonylureas | active | 2025-01 | us | hl7 | rx | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1078.978.json | OIA_RFs_ASCVD_ICD10 | active | 2025-01 | us | hl7 | icd | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1078.979.json | OIA_RFs_ASCVD_SNOMED | active | 2025-01 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1078.98.json | BMI LOINC | active | 2024-03 | us | hl7 | loinc | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1078.980.json | OIA_RFs_ASCVD_ICD10_SNOMED | active | 2025-01 | us | hl7 | vsac | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1078.981.json | OIA_TIA_ICD10 | active | 2025-01 | us | hl7 | icd | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1078.982.json | OIA_TIA_SNOMED | active | 2025-01 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1078.983.json | OIA_TIA_ICD10_SNOMED | active | 2025-01 | us | hl7 | vsac | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1078.984.json | OIA_Angina_ICD10 | active | 2025-01 | us | hl7 | icd | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1078.985.json | OIA_Angina_SNOMED | active | 2025-01 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1078.987.json | OIA_Angina_ICD10_SNOMED | active | 2025-01 | us | hl7 | vsac | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1078.988.json | OIA_Ischemic_Hemorrhagic_Stroke_ICD10 | active | 2025-01 | us | hl7 | icd | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1078.989.json | OIA_Ischemic_Hemorrhagic_Stroke_SNOMED | active | 2025-01 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1078.990.json | OIA_Ischemic_Hemorrhagic_Stroke_ICD10_SNOMED | active | 2025-01 | us | hl7 | vsac | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1078.991.json | OIA_Myocardial_Infarction_ICD10 | active | 2025-01 | us | hl7 | icd | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1078.992.json | OIA_Myocardial_Infarction_SNOMED | active | 2025-01 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1078.993.json | OIA_Myocardial_Infarction_ICD10_SNOMED | active | 2025-01 | us | hl7 | vsac | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1078.995.json | OIA_PAD_ICD10 | active | 2025-01 | us | hl7 | icd | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1078.996.json | OIA_PAD_SNOMED | active | 2025-01 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1078.997.json | OIA_PAD_ICD10_SNOMED | active | 2025-01 | us | hl7 | vsac | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1078.998.json | OIA_Coronary_Arterial_Revascularization | active | 2025-01 | us | hl7 | cpt | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1080.5.json | Contact or Office Visit | active | 2022-02 | us | hl7 | vsac | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1080.6.json | Contact or Office Visit | active | 2025-02 | us | hl7 | cpt | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1080.7.json | Contact or Office Visit | active | 2022-02 | us | hl7 | cms | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1095.10.json | Nutrition Diagnosis SNOMED CT | active | 2025-01 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1095.101.json | Hospice Status | active | 2024-10 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1095.14.json | Vitamin Mineral Supplement and Bioactive Substance Management SNOMED CT | active | 2020-08 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1095.17.json | Pediatric Enteral Formulas SNOMED CT | active | 2021-04 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1095.18.json | Modified Amino Acid Formulas SNOMED CT | active | 2024-04 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1095.19.json | Nutrition Counseling Approach and Strategies SNOMED CT | active | 2020-09 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1095.20.json | Enteral Nutrition Management SNOMED CT | active | 2020-09 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1095.21.json | Nutrition Assessment | active | 2024-01 | us | hl7 | loinc | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1095.25.json | Nutritional Status Severely Malnourished | active | 2016-12 | us | hl7 | icd | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1095.30.json | Malnutrition Risk Screening | active | 2015-11 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1095.31.json | Malnutrition At Risk | active | 2015-11 | us | hl7 | icd | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1095.32.json | Malnutrition Risk Screening | active | 2016-12 | us | hl7 | icd | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1095.34.json | Malnutrition Screening Finding of Not At Risk Result | active | 2024-01 | us | hl7 | loinc | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1095.35.json | Malnutrition Screening Not at Risk | active | 2015-11 | us | hl7 | icd | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1095.38.json | Malnutrition Screening Finding of At Risk Result | active | 2025-01 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1095.39.json | Malnutrition Risk Screening | active | 2016-12 | us | hl7 | icd | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1095.40.json | Malnutrition Risk Screening | active | 2022-02 | us | hl7 | vsac | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1095.41.json | Nutritional Status Severely Malnourished | active | 2025-02 | us | hl7 | icd | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1095.42.json | Nutrition Assessment Status Finding of Severely Malnourished | active | 2024-12 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1095.43.json | Nutrition Assessment Status Finding of Severely Malnourished | active | 2024-01 | us | hl7 | vsac | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1095.44.json | Nutrition Assessment Status Finding of Moderately Malnourished | active | 2024-01 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1095.45.json | Nutritional Status Moderately Malnourished | active | 2015-11 | us | hl7 | icd | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1095.46.json | Nutritional Status Moderately Malnourished | active | 2025-02 | us | hl7 | icd | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1095.47.json | Nutrition Assessment Status Finding of Moderately Malnourished | active | 2024-01 | us | hl7 | vsac | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1095.48.json | Nutrition Assessment Status Finding of Well Nourished or Not Malnourished or Mildly Malnourished | active | 2024-01 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1095.49.json | Nutrition Focused Physical Findings Grouping | active | 2022-03 | us | hl7 | vsac | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1095.5.json | Adult Enteral Formulas SNOMED CT | active | 2024-04 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1095.50.json | Enteral Nutrition Composition SNOMED CT | active | 2024-04 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1095.51.json | Enteral Nutrition Composition Grouping | active | 2022-03 | us | hl7 | vsac | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1095.52.json | Parenteral Nutrition Management SNOMED CT | active | 2020-09 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1095.53.json | Malnutrition Diagnosis | active | 2024-12 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1095.54.json | Malnutrition Diagnosis | active | 2025-02 | us | hl7 | icd | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1095.55.json | Malnutrition Diagnosis | active | 2022-03 | us | hl7 | vsac | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1095.56.json | Malnutrition Diagnosis | active | 2016-09 | us | hl7 | icd | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1095.59.json | Diet Item Grouping | active | 2018-04 | us | hl7 | vsac | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1095.60.json | Edible Substances | active | 2021-04 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1095.61.json | Feeding Device SNOMED CT | active | 2021-04 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1095.65.json | Nutrition Recommendation Grouping | active | 2025-02 | us | hl7 | vsac | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1095.7.json | Modular Nutrition Formulas SNOMED CT | active | 2021-04 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1095.71.json | Coordination of Care by a Nutrition Professional SNOMED CT | active | 2024-04 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1095.73.json | Nutrition Anthropometric Measurement SNOMED CT | active | 2024-05 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1095.74.json | Nutrition Anthropometric Measure Panel LOINC | active | 2024-05 | us | hl7 | loinc | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1095.75.json | Nutrition Anthropometric Measurements Grouping | active | 2018-04 | us | hl7 | vsac | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1095.76.json | Manage Feeding Environment | active | 2021-04 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1095.77.json | Special Food Items and Regime/Therapy for Special Food Items SNOMED CT | active | 2021-04 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1095.78.json | Food and Nutrition Related History LOINC | active | 2024-04 | us | hl7 | loinc | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1095.79.json | Nutrition Encounter Individual and Group CPT | active | 2025-02 | us | hl7 | cpt | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1095.80.json | Nutrition Encounters HCPCS | active | 2025-02 | us | hl7 | cms | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1095.81.json | Nutrition Encounter Codes Grouping | active | 2018-04 | us | hl7 | vsac | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1095.84.json | Food and Nutrition Related History SNOMED CT | active | 2024-04 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1095.87.json | Feeding Device Grouping | active | 2018-05 | us | hl7 | vsac | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1095.88.json | Nutrition Intervention Care Planning | active | 2022-03 | us | hl7 | vsac | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1095.89.json | Malnutrition Screening Finding of At Risk Result | active | 2024-01 | us | hl7 | vsac | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1095.90.json | Medical Nutrition Therapy Procedures | active | 2025-03 | us | hl7 | cpt | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1095.91.json | Dietitian Referral | active | 2024-12 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1095.92.json | Malnutrition Risk Screening | active | 2024-01 | us | hl7 | loinc | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1095.93.json | Nutrition Care Plan | active | 2024-01 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1095.94.json | Malnutrition Screening Finding of At Risk Result | active | 2024-01 | us | hl7 | loinc | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1095.95.json | Nutrition Assessment Status Finding of Well Nourished or Not Malnourished or Mildly Malnourished | active | 2024-01 | us | hl7 | loinc | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1095.96.json | Nutrition Assessment Status Finding of Well Nourished or Not Malnourished or Mildly Malnourished | active | 2024-01 | us | hl7 | vsac | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1095.97.json | Nutrition Assessment Status Finding of Severely Malnourished | active | 2024-01 | us | hl7 | loinc | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1095.98.json | Nutrition Assessment Status Finding of Moderately Malnourished | active | 2024-01 | us | hl7 | loinc | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1096.1.json | Findings Related to Medication Management, Referral Source | active | 2023-12 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1096.100.json | Recommendations Related to Medication Regimen | active | 2022-03 | us | hl7 | vsac | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1096.101.json | Interventions Related to Medication Regimen, Initiate Medication | active | 2017-08 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1096.102.json | Interventions Related to Medication Regimen, Change Medication | active | 2021-03 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1096.103.json | Interventions Related to Medication Regimen, Change Medication Dose | active | 2024-02 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1096.104.json | Interventions Related to Medication Regimen, Change Medication Dosage Form | active | 2017-08 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1096.105.json | Interventions Related to Medication Regimen, Change Medication Course | active | 2017-08 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1096.106.json | Interventions Related to Medication Regimen, Change Medication Dosing Interval | active | 2017-08 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1096.107.json | Interventions Related to Medication Regimen, Discontinue Medication | active | 2017-08 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1096.109.json | Interventions Related to Medication Regimen | active | 2022-03 | us | hl7 | vsac | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1096.11.json | Interventions Related to Medication Management, Medication Reconciliation | active | 2017-08 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1096.110.json | Interventions Related to Education, Medications | active | 2020-08 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1096.111.json | Interventions Related to Education, Medical Equiptment and Devices | active | 2023-12 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1096.112.json | Interventions Related to Medication Management, Notifications | active | 2017-08 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1096.113.json | Interventions Related to Medication Management, Refill Synchronization | active | 2017-08 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1096.114.json | Status of Patient Condition | active | 2017-08 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1096.115.json | Interventions Related to Education, Diseases and Disorders | active | 2023-12 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1096.116.json | Interventions Related to Education | active | 2022-03 | us | hl7 | vsac | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1096.118.json | Interventions Related to Medication Management | active | 2022-03 | us | hl7 | vsac | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1096.119.json | Interventions Related to Medication Management, Targeted Medication Review | active | 2024-02 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1096.120.json | Interventions Related to Medication Management, Discussion | active | 2021-03 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1096.121.json | Reasons for Interventions Related to Medication Management, Cost | active | 2019-06 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1096.122.json | Interventions Related to Education, Immunizations | active | 2017-08 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1096.123.json | Status of Recommendations | active | 2023-12 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1096.124.json | Interventions Related to Medication Management, Provision of Documents | active | 2017-08 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1096.125.json | Status of Compliance Ability | active | 2017-08 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1096.126.json | Status of Interventions | active | 2017-08 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1096.127.json | Status of Disease Control | active | 2017-08 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1096.128.json | Status of Compliance | active | 2017-08 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1096.129.json | Occupations of Providers | active | 2019-06 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1096.130.json | Environments of Care | active | 2017-08 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1096.131.json | Findings Related to Medication Management, Body Mass Index | active | 2017-08 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1096.132.json | Findings Related to Medication Management, Alcohol Use | active | 2019-06 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1096.133.json | Findings Related to Medication Management, Caffeine Use | active | 2019-06 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1096.134.json | Interventions Related to Education, Diet | active | 2024-02 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1096.136.json | Findings Related to Medication Management, Exercise | active | 2017-08 | us | hl7 | sct |